The stomach and/or upper duodenum contain sites of action that control meal size and intermeal interval length by exogenous rat gastrin releasing peptide |
| |
| Affiliation: | 1. Gastroenterology Laboratory, Department of Biomedical Sciences, College of Veterinary Medicine, Tuskegee University, Tuskegee, AL 36088, United States;2. School of Medicine, Wayne State University, Detroit, MI 48202, United States;1. Intervention Division, Taiyuan City Centre Hospital, Taiyuan 030001, China;2. Cadre Health Centre, Qinghai People''s Hospital, Xining 810000, China;3. Department of Senile Internal Medicine, Second Hospital of Shanxi Medical University, Taiyuan 030001, China;1. Smooth Muscle Research Centre, Dundalk Institute of Technology, Dublin Road, Co. Louth, Ireland;2. Molecular Medicine Laboratories, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Co. Dublin, Ireland;1. Vírgen del Rocío University Hospital, Research Laboratory on Neuropeptides Sevilla, Spain;2. Hospital Juan Ramón Jiménez, Huelva, Spain;3. Deparment of Pathology, “Vírgen del Rocío” University Hospital, Sevilla, Spain;4. Institute of Neurosciences of Castilla y León (INCYL) , Laboratory of Neuroanatomy of the Peptidergic Systems, Laboratory 14, Salamanca, Spain;1. Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale, F-31077 Toulouse, France;2. Université de Toulouse, Université Paul Sabatier, Institut de Pharmacologie et de Biologie Structurale, F-31077 Toulouse, France;1. CNR Institute of Clinical Physiology, Laboratory of Cardiovascular Biochemistry, Pisa, Italy;2. CNR Institute of Clinical Physiology, Milan, Italy;3. Cardiovascular Department, Niguarda Ca’ Granda Hospital, Milan, Italy |
| |
| Abstract: | The site(s) of action that control the reduction of food intake in response to the amphibian skin peptide bombesin (Bn) has been determined to be the area supplied by the celiac artery (CA), i.e., the stomach and the upper duodenum. Here, we investigated the gastrointestinal site(s) of action which controls meal size (MS) (normal rat chow) and intermeal interval length (IMI) by the mammalian homologues of Bn gastrin releasing peptides (GRP-10, GRP-27 and GRP-29, 0.01, 0.05, 0.1, 0.2 and 0.5 nmol/kg) infused in the CA, the cranial mesenteric artery (CMA, supplying the small and large intestine), the femoral artery (FA, control) and the portal vein (PV, draining the gastrointestinal tract, control) in freely fed rats immediately prior to the onset of the dark cycle. We found that (1) GRP-29 (0.05, 0.1, 0.2 and 0.5 nmol/kg) and GRP-27 (0.2 and 0.5 nmol/kg) in the CA and GRP-29 (0.5 nmol/kg) in the CMA reduced the MS relative to saline, (2) GRP-29 (0.1, 0.2 and 0.5 nmol/kg) and GRP-27 (0.2 and 0.5 nmol/kg) in the CA prolonged the IMI, (3) GRP-29 (0.1, 0.2 and 0.5 nmol/kg) in the CA and GRP-29 (0.5 nmol/kg) in the CMA increased the satiety ratio (SR, IMI/MS – the amount of food consumed per a given unit of time) and (4) neither peptide nor route showed any effect on the second MS. These results support an upper gastrointestinal site of action for MS and IMI length by GRP-27 and GRP-29, which is most likely the stomach and/or the duodenum. |
| |
| Keywords: | GRP Celiac artery Cranial mesenteric artery Portal vein Food intake |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
